Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05148156
NA

Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.

Sponsor: Northwell Health

View on ClinicalTrials.gov

Summary

Many patients may face long-term urinary side effects following stereotactic body radiation therapy (SBRT), including increased urinary frequency, dysuria, and nocturia. The investigator hypothesizes that Urolift, which represents a novel minimally invasive therapy, may reduce acute and long-term urinary toxicity and side effects of radiation therapy (SBRT).

Official title: Reduction of Urinary Toxicity of Stereotactic Body Radiation Therapy (SBRT) With Prostatic Urethral Lift (Urolift)

Key Details

Gender

MALE

Age Range

50 Years - 99 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2026-02-11

Completion Date

2028-03

Last Updated

2026-09-29

Healthy Volunteers

Yes

Interventions

DEVICE

Urolift

Study intervention involves a one-time administration of Urolift in out-patient setting prior to Stereotactic body radiation therapy (SBRT).

Locations (1)

Northwell Health

Syosset, New York, United States